SCHEMBL21394918

SCHEMBL21394918

Cc1nccc(C(=O)Nc2ccc(Cc3cc(F)cc(F)c3)cn2)n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 8/20 0.43
WNT3A P56704 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
KCNH2 Q12809 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP3A4 P08684 1/20 0.39
SLC6A3 Q01959 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HCRTR1 O43613 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SORT1 Q99523 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21394865 0.90 NR3C2 (0.47) GRM5WNT3ANPC1RAB9ATP53
SCHEMBL29358065 0.90 NR3C2 (0.47) GRM5WNT3ANPC1RAB9ATP53
SCHEMBL21394779 0.90 GPR6 (0.41) GRM5
SCHEMBL29356981 0.90 GPR6 (0.41) GRM5
SCHEMBL21395082 0.88 NPC1 (0.43) GRM5WNT3ACYP1A2CYP2C9KDM4E
SCHEMBL22479673 0.86 NPC1 (0.47) GRM5CYP1A2CYP2C9CYP3A4NPC1
SCHEMBL29353664 0.83 GRM4 (0.43) GRM5WNT3ANPC1RAB9A
SCHEMBL21395200 0.83 GRM4 (0.43) GRM5WNT3ANPC1RAB9A
SCHEMBL21394613 0.83 ALDH1A1 (0.48) NPC1RAB9AHCRTR1TP53MAPT
SCHEMBL29357133 0.83 ALDH1A1 (0.48) NPC1RAB9AHCRTR1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198026-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed